The agency has provided few details about its AI pilot as it makes moves on its “aggressive timeline” for rollout.

Dubbed Elsa, the tool was expected to roll out at the end of June. The FDA says it marks the dawn of a new era.

The Food and Drug Administration has officially launched "Elsa," a generative artificial intelligence platform designed to ...

The agency has provided only limited details about its AI pilot as it advances an “aggressive timeline” for the tool's ...

The Food and Drug Administration has gone all in on AI since Martin Makary, M.D., took over the agency, most recently ...

The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...

The FDA has introduced ELSA, a groundbreaking AI tool designed to expedite the review process for drugs and medical devices.

The U.S. FDA announced this week that it deployed a generative AI tool called ELSA, now in use by staff across the agency, ...

Following a successful pilot, the Food and Drug Administration unveiled its in-house large language model designed to help ...

The FDA introduced Elsa, an artificial intelligence (AI) tool intended to enhance efficiency in clinical reviews and ...

Learn more about the generative AI technology that will be used at the Food and Drug Administration (FDA) to speed up reviews ...